Chargement en cours...

Is There a Role for α-Blockers for the Treatment of Voiding Dysfunction Unrelated to Benign Prostatic Hyperplasia?

α-Adrenoreceptor antagonists have become the primary medical treatment for lower urinary tract symptoms associated with benign prostatic hyperplasia (BPH). It was presumed that the primary mechanism by which α-blockers reduced lower urinary tract symptoms (LUTS) was by relaxation of smooth muscle in...

Description complète

Enregistré dans:
Détails bibliographiques
Auteur principal: Nitti, Victor W
Format: Artigo
Langue:Inglês
Publié: MedReviews, LLC 2005
Sujets:
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC1477610/
https://ncbi.nlm.nih.gov/pubmed/16986055
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!